Incyte Earnings, Revenue beat in Q4 By Investing.com

Incyte (NASDAQ:INCY) reported on Tuesday fourth quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

Incyte announced earnings per share of $0.93 on revenue of $789.5M. Analysts polled by Investing.com anticipated EPS of $0.5346 on revenue of $659.5M.

Incyte shares are down 5.75% from the beginning of the year and are trading at $93.62 , down-from-52-week-high.They are under-performing the S&P 500 which is up 4.25% from the start of the year.

Incyte follows other major Healthcare sector earnings this month

Incyte’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.

Roche Holding ADR had missed expectations on February 1 with fourth quarter EPS of $1.21 on revenue of $15.88B, compared to forecast for EPS of $1.28 on revenue of $16.45B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar